1st Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
7th — 9th October 2008
Hamburg, Germany
Program
|
The mosaic of autoimmunity: Novel aspects Yehuda Shoenfeld |
||||
|
Immunogenicity of therapeutic proteins Melody Sauerborn, Vera Brinks |
||||
|
Gyrolab® is a versatile and powerful bioanalytical platform for evaluating immunogenicity of recombinant therapeutic proteins Mats Inganäs |
||||
|
Increase of sample throughput on Biacore®, Example for anti-mAb-antibodies Kerstin Kröger (Novartis Biologics) |
||||
|
Detection of Anti-Drug Antibodies (ADA) in the Presence of Drug Denise Sickert (Novartis Biologics) |
||||
|
Clinical Experience in the Treatment of Fabry Disease Identifies the Need for Immunogenicity Assay Standardization Joan Keutzer, Daniel Gruskin, Susan Richards, John Yee (Genzyme Corporation) |
||||
|
Immunogenicity: The US Perspective Bonnie Rup (AAPS) |
||||
|
Clinical aspects of Immunogenicity Petersen (Novonordisk) |
||||
|
Risk analysis & risk management of immunogenicity Paul Chamberlain (bioLOGICA Consulting & NDA Advisory Board) |
||||
|
EMEA guidance on unwanted immunogenicity for biotherapeutics Robin Thorpe (NIBSC) |
||||
|
Protein Aggregation and Immunogenicity Mary Cromwell (Genentech) |
||||
|
Characterization and stability of heat-stressed insulin upon storage at 80 °C Ruedeeporn Tantipolphan |
||||
|
Controlled degradation and characterization of a Monoclonal Antibody for immunogenicity testing Vasco Filipe (LACDR) |
||||
|
The Need for Standardization of Immunogenicity Assays for Gaucher Disease Enzyme Replacement Therapy Joan Keutzer, Michael Yeh, Susan Richards, John Yee (Genzyme Corporation) |
||||
|
Detection of Anti-Idiotype Antibodies to Rituximab in Patients with Severe Pemphigus Enno Schmidt (University of Lübeck) |
||||
|
Workshop: Biosimilars and Comparability Paul Chamberlain (bioLOGICA Consulting & NDA Advisory Board) |
||||
|
Monoclonal Antibody Workshop Sue Stephens, Andy Popplewell (UCB) |